Observations

The WSLCB’s Cannabis 2.0 project is garnering the attention of leadership at other state agencies ahead of the 2020 legislative session.

A sparsely attended hearing provided an opportunity to learn more about the department’s Medical Marijuana Program, the patient registry, and upcoming rulemaking.

DOH hosts a public hearing on compassionate care renewals and the WSLCB Traceability Advisory Committee will consider how to exit from MJ Freeway.

Participants shared strategies to mitigate costs and phase-in new pesticide and heavy metals testing requirements for cannabis products in Washington state.

The scope of the vaping crisis continued to expand, including a possible case in Washington state and increased likelihood of federal and state action against flavored vapor products considered appealing to children.

The Board discussed agency and industry proposals for social equity programs as well as the latest news about vaping-related illnesses and deaths.

A new Traceability Data Sharing Agreement Work Group convenes, the lege asks for a marijuana update, and the Board confronts an emergent public health crisis attributed to vaping.

The Board denied a petition for rulemaking from a transporter and reacted to federal warnings about correlated health impacts attributed to vaping.

Details on the WSLCB’s social equity and Tier 1 vertical integration bills; labs; traceability; the Cannabis Potency Tax Work Group; and legislator interest in advertising loopholes.

Feedback on potential agency request legislation for social equity, smaller producers, and medical cannabis is due no later than Thursday September 4th.